Richard Law CFA
Stock Analyst at Goldman Sachs
(3.73)
# 2,087
Out of 4,675 analysts
131
Total ratings
50.7%
Success rate
9.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Richard Law CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Maintained: Buy | $39 → $40 | $24.80 | +61.29% | 11 | Aug 20, 2026 | |
| MLYS Mineralys Therapeutics | Maintained: Buy | $42 → $40 | $26.95 | +48.42% | 13 | Aug 12, 2026 | |
| PTGX Protagonist Therapeutics | Upgraded: Buy | $110 → $186 | $154.94 | +20.05% | 7 | Aug 11, 2026 | |
| OLMA Olema Pharmaceuticals | Maintained: Buy | $23 → $20 | $11.31 | +76.83% | 10 | Aug 11, 2026 | |
| RCUS Arcus Biosciences | Rated: Buy | $34 → $42 | $30.35 | +38.39% | 4 | Aug 10, 2026 | |
| CLDX Celldex Therapeutics | Maintained: Hold | $34 → $38 | $41.70 | -8.87% | 7 | Aug 7, 2026 | |
| SLN Silence Therapeutics | Maintained: Sell | $4 | $13.61 | -70.61% | 4 | Jul 27, 2026 | |
| COAG Hemab Therapeutics Holdings | Maintained: Buy | $36 → $46 | $51.66 | -10.96% | 2 | Jul 13, 2026 | |
| BCAX Bicara Therapeutics | Maintained: Hold | $18 | $25.86 | -30.39% | 4 | Jun 1, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Sell | $11 → $12 | $16.74 | -28.32% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $3 | $3.65 | -17.81% | 7 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $84.69 | -20.89% | 5 | Mar 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $29 → $33 | $26.46 | +24.72% | 3 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $33 | $35.98 | n/a | 2 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $36 → $31 | $15.84 | n/a | 6 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $47 | $29.07 | n/a | 4 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $62 → $63 | $59.81 | n/a | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $36 → $37 | $127.31 | n/a | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $13.28 | n/a | 7 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $15.77 | n/a | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $14 | $3.25 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $61 | $9.68 | n/a | 5 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $10 | $4.21 | n/a | 2 | Feb 24, 2023 |
Viridian Therapeutics
Aug 20, 2026
Maintained: Buy
Price Target: $39 → $40
Current: $24.80
Upside: +61.29%
Mineralys Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $42 → $40
Current: $26.95
Upside: +48.42%
Protagonist Therapeutics
Aug 11, 2026
Upgraded: Buy
Price Target: $110 → $186
Current: $154.94
Upside: +20.05%
Olema Pharmaceuticals
Aug 11, 2026
Maintained: Buy
Price Target: $23 → $20
Current: $11.31
Upside: +76.83%
Arcus Biosciences
Aug 10, 2026
Rated: Buy
Price Target: $34 → $42
Current: $30.35
Upside: +38.39%
Celldex Therapeutics
Aug 7, 2026
Maintained: Hold
Price Target: $34 → $38
Current: $41.70
Upside: -8.87%
Silence Therapeutics
Jul 27, 2026
Maintained: Sell
Price Target: $4
Current: $13.61
Upside: -70.61%
Hemab Therapeutics Holdings
Jul 13, 2026
Maintained: Buy
Price Target: $36 → $46
Current: $51.66
Upside: -10.96%
Bicara Therapeutics
Jun 1, 2026
Maintained: Hold
Price Target: $18
Current: $25.86
Upside: -30.39%
MoonLake Immunotherapeutics
May 11, 2026
Maintained: Sell
Price Target: $11 → $12
Current: $16.74
Upside: -28.32%
Mar 27, 2026
Maintained: Sell
Price Target: $3
Current: $3.65
Upside: -17.81%
Mar 1, 2026
Maintained: Buy
Price Target: $67
Current: $84.69
Upside: -20.89%
Feb 27, 2026
Maintained: Hold
Price Target: $29 → $33
Current: $26.46
Upside: +24.72%
Jul 24, 2025
Maintained: Hold
Price Target: $30 → $33
Current: $35.98
Upside: n/a
Aug 15, 2023
Maintained: Hold
Price Target: $36 → $31
Current: $15.84
Upside: n/a
Aug 9, 2023
Maintained: Hold
Price Target: $47
Current: $29.07
Upside: n/a
Aug 8, 2023
Maintained: Hold
Price Target: $62 → $63
Current: $59.81
Upside: n/a
Aug 4, 2023
Maintained: Hold
Price Target: $36 → $37
Current: $127.31
Upside: n/a
Jun 13, 2023
Reiterated: Buy
Price Target: $76
Current: $13.28
Upside: n/a
May 12, 2023
Reiterated: Hold
Price Target: $11
Current: $15.77
Upside: n/a
May 5, 2023
Maintained: Hold
Price Target: $15 → $14
Current: $3.25
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $61
Current: $9.68
Upside: n/a
Feb 24, 2023
Upgraded: Hold
Price Target: $10
Current: $4.21
Upside: n/a